Covering the trending news and insights on the Healthcare and Life Sciences sectors in Q1 and Q2, our 2023 Half Year in Review Healthcare and Life Sciences Market Update Report outlines: Private Equity, Private Health, Public Health, Resigning or ‘Quietly Quitting’, Executive Remuneration, Virtual Healthcare, Life Sciences across Asia, ANZ and the Middle East. |
| A note from C-Suite Partners’ Asia Pacific Partner, Jessi Carroll: |
“In 2023, the executive candidate market is experiencing a remarkable resurgence with a strong market favouring candidates, driving significant opportunities for career progression. We continue to observe a growing interest in Private Equity with healthcare executives as both global and local firms target exceptional healthcare CEOs, who are transitioning to portfolio careers. Major shifts at the Director General level and local hospital level continue to drive executive requirements in the public sector. With the financial challenges being felt in the private sector, executives who demonstrate strategic and operational leadership, strong financial and commercial acumen, best practice clinical governance and resilience are well placed to thrive in this dynamic market.” |
Menu
